全文获取类型
收费全文 | 7805篇 |
免费 | 660篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 121篇 |
儿科学 | 186篇 |
妇产科学 | 201篇 |
基础医学 | 910篇 |
口腔科学 | 91篇 |
临床医学 | 1192篇 |
内科学 | 1387篇 |
皮肤病学 | 66篇 |
神经病学 | 642篇 |
特种医学 | 148篇 |
外科学 | 1056篇 |
综合类 | 107篇 |
一般理论 | 4篇 |
预防医学 | 1154篇 |
眼科学 | 83篇 |
药学 | 592篇 |
中国医学 | 1篇 |
肿瘤学 | 535篇 |
出版年
2023年 | 59篇 |
2022年 | 74篇 |
2021年 | 193篇 |
2020年 | 124篇 |
2019年 | 203篇 |
2018年 | 237篇 |
2017年 | 163篇 |
2016年 | 188篇 |
2015年 | 197篇 |
2014年 | 247篇 |
2013年 | 350篇 |
2012年 | 553篇 |
2011年 | 562篇 |
2010年 | 306篇 |
2009年 | 248篇 |
2008年 | 399篇 |
2007年 | 423篇 |
2006年 | 436篇 |
2005年 | 468篇 |
2004年 | 396篇 |
2003年 | 393篇 |
2002年 | 333篇 |
2001年 | 126篇 |
2000年 | 155篇 |
1999年 | 125篇 |
1998年 | 57篇 |
1997年 | 66篇 |
1996年 | 54篇 |
1995年 | 51篇 |
1994年 | 29篇 |
1993年 | 54篇 |
1992年 | 86篇 |
1991年 | 78篇 |
1990年 | 55篇 |
1989年 | 68篇 |
1988年 | 45篇 |
1987年 | 67篇 |
1986年 | 71篇 |
1985年 | 75篇 |
1984年 | 49篇 |
1983年 | 44篇 |
1981年 | 29篇 |
1979年 | 45篇 |
1978年 | 28篇 |
1974年 | 32篇 |
1973年 | 39篇 |
1972年 | 33篇 |
1970年 | 28篇 |
1969年 | 30篇 |
1967年 | 28篇 |
排序方式: 共有8476条查询结果,搜索用时 8 毫秒
991.
992.
993.
994.
995.
996.
997.
M.G. Gillespie 《American journal of surgery》1942,57(2):348-351
A patient (age seventy-nine) is presented who was operated upon for carcinoma of the stomach. Total gastrectomy was performed. The patient made an uneventful convalescence and I believe is the oldest patient to survive this procedure. At the time of this writing, almost three months following operation, his recovery has continued to run a smooth course. 相似文献
998.
Colleen Bamford Lucille H. Blumberg Michelle Bosman John Frean Kim G.P. Hoek Janet Miles Charlotte Sriruttan Ilse Vorster Marinda C. Oosthuizen 《Emerging infectious diseases》2023,29(2):407
We describe a case of neoehrlichiosis in an immunocompetent child with acute febrile illness in South Africa. Neoehrlichiosis was diagnosed by PCR on 16S rDNA from bone marrow aspirate. Phylogenetic analysis indicated an organism closely related to Candidatus Neoehrlichia. Clinicians should be aware of possible ehrlichiosis even in immunocompetent patients. 相似文献
999.
Kashif Mehmood Michael P. Wilczek Jeanne K. DuShane Matthew T. Parent Colleen L. Mayberry Jaqulin N. Wallace Francois L. Levasseur Tristan M. Fong Samuel T. Hess Melissa S. Maginnis 《Viruses》2022,14(12)
The organization and dynamics of plasma membrane receptors are a critical link in virus-receptor interactions, which finetune signaling efficiency and determine cellular responses during infection. Characterizing the mechanisms responsible for the active rearrangement and clustering of receptors may aid in developing novel strategies for the therapeutic treatment of viruses. Virus-receptor interactions are poorly understood at the nanoscale, yet they present an attractive target for the design of drugs and for the illumination of viral infection and pathogenesis. This study utilizes super-resolution microscopy and related techniques, which surpass traditional microscopy resolution limitations, to provide both a spatial and temporal assessment of the interactions of human JC polyomavirus (JCPyV) with 5-hydroxytrypamine 2 receptors (5-HT2Rs) subtypes during viral entry. JCPyV causes asymptomatic kidney infection in the majority of the population and can cause fatal brain disease, and progressive multifocal leukoencephalopathy (PML), in immunocompromised individuals. Using Fluorescence Photoactivation Localization Microscopy (FPALM), the colocalization of JCPyV with 5-HT2 receptor subtypes (5-HT2A, 5-HT2B, and 5-HT2C) during viral attachment and viral entry was analyzed. JCPyV was found to significantly enhance the clustering of 5-HT2 receptors during entry. Cluster analysis of infected cells reveals changes in 5-HT2 receptor cluster attributes, and radial distribution function (RDF) analyses suggest a significant increase in the aggregation of JCPyV particles colocalized with 5-HT2 receptor clusters in JCPyV-infected samples. These findings provide novel insights into receptor patterning during viral entry and highlight improved technologies for the future development of therapies for JCPyV infection as well as therapies for diseases involving 5-HT2 receptors. 相似文献
1000.
C L Williams R Fareed G L M Mortimer R J Aitken I V Wilson G George K M Gillespie A J K Williams The BOX Study Group A E Long 《Clinical and experimental immunology》2022,210(2):151
The clinical usefulness of post-diagnosis islet autoantibody levels is unclear and factors that drive autoantibody persistence are poorly defined in type 1 diabetes (T1D). Our aim was to characterise the longitudinal loss of islet autoantibody responses after diagnosis in a large, prospectively sampled UK cohort. Participants with T1D [n = 577] providing a diagnosis sample [range −1.0 to 2.0 years] and at least one post-diagnosis sample (<32.0 years) were tested for autoantibodies to glutamate decarboxylase 65 (GADA), islet antigen-2 (IA-2A), and zinc transporter 8 (ZnT8A). Select HLA and non-HLA SNPs were considered. Non-genetic and genetic factors were assessed by multivariable logistic regression models for autoantibody positivity at initial sampling and autoantibody loss at final sampling. For GADA, IA-2A, and ZnT8A, 70.8%, 76.8%, and 40.1%, respectively, remained positive at the final sampling. Non-genetic predictors of autoantibody loss were low baseline autoantibody titres (P < 0.0001), longer diabetes duration (P < 0.0001), and age-at-onset under 8 years (P < 0.01–-0.05). Adjusting for non-genetic covariates, GADA loss was associated with low-risk HLA class II genotypes (P = 0.005), and SNPs associated with autoimmunity RELA/11q13 (P = 0.017), LPP/3q28 (P = 0.004), and negatively with IFIH1/2q24 (P = 0.018). IA-2A loss was not associated with genetic factors independent of other covariates, while ZnT8A loss was associated with the presence of HLA A*24 (P = 0.019) and weakly negatively with RELA/11q13 (P = 0.049). The largest longitudinal study of islet autoantibody responses from diagnosis of T1D shows that autoantibody loss is heterogeneous and influenced by low titres at onset, longer duration, earlier age-at-onset, and genetic variants. These data may inform clinical trials where post-diagnosis participants are recruited. 相似文献